← Leaderboards
Shin H Kang
Temple Univ Of The Commonwealth
$4,777,416
Attributed
$4,777,416
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $738.9K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,777,416 · 3
By mechanism
R01$4,243,503 · 2
R56$533,913 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Michael Edgar Selzer$13,783,841
- Gareth Thomas$4,978,446
- Sãbastien Hãbert$230,079
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAstrocytesCellsSourceNutritional SupportPlayMicrogliaMetabolicMouse ModelNatural RegenerationNeuronsCell CommunicationOligodendrogliaFunctional DisorderNeurogliaCell TypeTargeted TreatmentGenetic ManipulationMolecularMotorDisease ProgressionDisease PhenotypeExperimental StudyMutant
Grant awards (10)
Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease$721,936
R01 · FY2025 · AG · contact PI
Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease$727,334
R01 · FY2024 · AG · contact PI
Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease$738,916
R01 · FY2023 · AG · contact PI
Role of oligodendrocyte-derived IL-33 in brain aging and Alzheimer's disease$533,913
R56 · FY2022 · AG · contact PI
Role of Oligodendroglia in the Pathogenesis of ALS$340,104
R01 · FY2020 · NS · contact PI
Role of Oligodendroglia in the Pathogenesis of ALS$354,797
R01 · FY2019 · NS · contact PI
Role of Oligodendroglia in the Pathogenesis of ALS$340,104
R01 · FY2019 · NS · contact PI
Role of Oligodendroglia in the Pathogenesis of ALS$340,104
R01 · FY2018 · NS · contact PI
Role of Oligodendroglia in the Pathogenesis of ALS$340,104
R01 · FY2017 · NS · contact PI
Role of Oligodendroglia in the Pathogenesis of ALS$340,104
R01 · FY2016 · NS · contact PI